Stocks
Deciphera Pharmaceuticals (DCPH) EV/EBITDA US GAAP (year values) |
||||||||
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | LTM ? | |||
| EV/EBITDA | ? | -11.5 | -10.1 | -1.05 | 1.73 | 1.34 | 1.27 | |
| Changes by years, y/y, % | +148% | -12% | -90% | -264% | -22% | |||
Deciphera Pharmaceuticals. EV/EBITDA
Deciphera Pharmaceuticals. EV/EBITDA, changes, %
Deciphera Pharmaceuticals (DCPH) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2023Q1 | FY2023Q2 | FY2023Q3 | FY2023Q4 | FY2024Q1 | LTM ? | |||
| EV/EBITDA | ? | -5.10 | -4.75 | 1.55 | 1.39 | 1.27 | 1.27 | |
| Changes by years, y/y, % | +356% | +105% | -130% | -19% | -125% | |||
| Changes by quarters, q/q, % | -396% | -7% | -133% | -10% | -9% | |||
